Cardiovascular disease in patients with rheumatoid arthritis: impact of classic and disease-specific risk factors.
作者信息
Cavalli Giulio, Favalli Ennio Giulio
机构信息
Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy.
Vita-Salute San Raffaele University, Milan, Italy.
出版信息
Ann Transl Med. 2018 Nov;6(Suppl 1):S82. doi: 10.21037/atm.2018.10.72.
Abstract
摘要
相似文献
1
Cardiovascular disease in patients with rheumatoid arthritis: impact of classic and disease-specific risk factors.类风湿关节炎患者的心血管疾病：经典危险因素和疾病特异性危险因素的影响
Ann Transl Med. 2018 Nov;6(Suppl 1):S82. doi: 10.21037/atm.2018.10.72.
2
Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives.类风湿关节炎的心血管疾病：现状与未来展望。
Ann Rheum Dis. 2011 Jan;70(1):8-14. doi: 10.1136/ard.2010.142133. Epub 2010 Nov 24.
3
Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of prevention.类风湿关节炎与心血管疾病：全身炎症的作用及不断发展的预防策略
Curr Opin Rheumatol. 2005 May;17(3):234-41. doi: 10.1097/01.bor.0000159924.97019.25.
4
Cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions.类风湿关节炎中的心血管疾病：疾病与治疗的相互作用及其对治疗决策的影响
J Miss State Med Assoc. 2010 Mar;51(3):75-80.
5
[Rheumatoid arthritis - an independent risk factor for cardiovascular disease].类风湿关节炎——心血管疾病的独立危险因素
Vnitr Lek. 2012 Nov;58(11):834-8.
6
Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications.类风湿关节炎患者心血管风险增加：机制与意义。
BMJ. 2018 Apr 23;361:k1036. doi: 10.1136/bmj.k1036.
7
Prescribing Trend of Antirheumatic Drugs in Taiwan and Risk of Cardiovascular Disease in Patients with Rheumatoid Arthritis: A Nationwide Cohort Study.台湾抗风湿药物的处方趋势与类风湿性关节炎患者的心血管疾病风险：一项全国性队列研究。
Biomed Res Int. 2019 Feb 20;2019:7987529. doi: 10.1155/2019/7987529. eCollection 2019.
8
Utility of different cardiovascular disease prediction models in rheumatoid arthritis.不同心血管疾病预测模型在类风湿关节炎中的效用
J Med Life. 2014 Oct-Dec;7(4):588-94.
9
Translation and adaptation of the French version of the Heart Disease Fact Questionnaire - Rheumatoid Arthritis (HDFQ-RA 1&2).《心脏病问卷 - 类风湿关节炎（HDFQ-RA 1&2）》法译版的翻译和改编。
Joint Bone Spine. 2017 Dec;84(6):693-698. doi: 10.1016/j.jbspin.2016.09.016. Epub 2016 Nov 4.
10
Impact of parental history on patients' cardiovascular mortality in rheumatoid arthritis.父母病史对类风湿关节炎患者心血管死亡率的影响。
Ann Rheum Dis. 2006 Jun;65(6):741-5. doi: 10.1136/ard.2005.039990. Epub 2005 Oct 25.
引用本文的文献
1
Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment.类风湿关节炎的全身并发症：关注发病机制和治疗。
Front Immunol. 2022 Dec 22;13:1051082. doi: 10.3389/fimmu.2022.1051082. eCollection 2022.
2
Adult-Onset Still's Disease-A Complex Disease, a Challenging Treatment.成人斯蒂尔病——一种复杂的疾病，一种具有挑战性的治疗方法。
Int J Mol Sci. 2022 Oct 24;23(21):12810. doi: 10.3390/ijms232112810.
3
Heart rate and heart rate variability in patients with chronic inflammatory joint disease: the role of pain duration and the insular cortex.慢性炎性关节病患者的心率和心率变异性：疼痛持续时间和脑岛皮层的作用。
BMC Musculoskelet Disord. 2022 Jan 21;23(1):75. doi: 10.1186/s12891-022-05009-1.
4
Understanding the Role of Interleukin-6 (IL-6) in the Joint and Beyond: A Comprehensive Review of IL-6 Inhibition for the Management of Rheumatoid Arthritis.了解白细胞介素-6（IL-6）在关节及其他方面的作用：关于IL-6抑制治疗类风湿关节炎的综合综述。
Rheumatol Ther. 2020 Sep;7(3):473-516. doi: 10.1007/s40744-020-00219-2. Epub 2020 Jul 30.
本文引用的文献
1
Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus.TNF 抑制剂治疗失败的类风湿关节炎患者的转换或切换策略？意大利专家共识的修改结果。
Rheumatology (Oxford). 2018 Oct 1;57(57 Suppl 7):vii42-vii53. doi: 10.1093/rheumatology/key195.
2
The Expanded Risk Score in Rheumatoid Arthritis (ERS-RA): performance of a disease-specific calculator in comparison with the traditional prediction scores in the assessment of the 10-year risk of cardiovascular disease in patients with rheumatoid arthrit.类风湿关节炎扩展风险评分（ERS-RA）：与传统预测评分相比，一种疾病特异性计算器在评估类风湿关节炎患者心血管疾病10年风险中的表现
Swiss Med Wkly. 2018 Aug 22;148:w14656. doi: 10.4414/smw.2018.14656. eCollection 2018 Aug 13.
3
Treatment of Dilated Cardiomyopathy With Interleukin-1 Inhibition.白细胞介素-1抑制治疗扩张型心肌病
Ann Intern Med. 2018 Dec 4;169(11):819-820. doi: 10.7326/L18-0315. Epub 2018 Jul 31.
4
Interleukin-37 treatment of mice with metabolic syndrome improves insulin sensitivity and reduces pro-inflammatory cytokine production in adipose tissue.白细胞介素-37 治疗代谢综合征小鼠可改善胰岛素敏感性并减少脂肪组织中促炎细胞因子的产生。
J Biol Chem. 2018 Sep 14;293(37):14224-14236. doi: 10.1074/jbc.RA118.003698. Epub 2018 Jul 13.
5
Myocarditis: An Interleukin-1-Mediated Disease?心肌炎：一种由白细胞介素-1介导的疾病？
Front Immunol. 2018 Jun 13;9:1335. doi: 10.3389/fimmu.2018.01335. eCollection 2018.
6
How advances in personalized medicine will change rheumatology.个性化医疗的进展将如何改变风湿病学。
Per Med. 2018 Mar;15(2):75-78. doi: 10.2217/pme-2017-0079. Epub 2018 Feb 2.
7
Sex and Management of Rheumatoid Arthritis.性别与类风湿关节炎的管理。
Clin Rev Allergy Immunol. 2019 Jun;56(3):333-345. doi: 10.1007/s12016-018-8672-5.
8
Mechanisms of vascular comorbidity in autoimmune diseases.自身免疫性疾病中血管合并症的发生机制。
Curr Opin Rheumatol. 2018 Mar;30(2):197-206. doi: 10.1097/BOR.0000000000000483.
9
Prevalence of Takayasu arteritis in young women with acute ischemic heart disease.青年女性急性缺血性心脏病患者中 Takayasu 动脉炎的患病率。
Int J Cardiol. 2018 Feb 1;252:21-23. doi: 10.1016/j.ijcard.2017.10.067.
10
The management of first-line biologic therapy failures in rheumatoid arthritis: Current practice and future perspectives.类风湿关节炎一线生物治疗失败的管理：现状与未来展望。
Autoimmun Rev. 2017 Dec;16(12):1185-1195. doi: 10.1016/j.autrev.2017.10.002. Epub 2017 Oct 14.
Zotero 插件